ANDEMBRY 200 MG in 1.2 ML Auto-Injector
- RxCUI
- 2717182
- RxNorm name
- ANDEMBRY 200 MG in 1.2 ML Auto-Injector
- Display name
- ANDEMBRY 200 MG in 1.2 ML Auto-Injector
- Full name
- ANDEMBRY 200 MG in 1.2 ML Auto-Injector
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761367 | Andembry | garadacimab-gxii | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ANDEMBRY | GARADACIMAB | CSL | 07b0b671-db81-49f0-a402-0c0219db7fa2 | 2025-06-30 | Warnings, Adverse reactions | 2717182 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 07b0b671-db81-49f0-a402-0c0219db7fa2 | ANDEMBRY 200 MG in 1.2 ML Auto-Injector | PSN | 5 | These highlights do not include all the information needed to use ANDEMBRY safely and effectively. See full prescribing information for ANDEMBRY. ANDEMBRY ® (garadacimab-gxii) injection, for subcutaneous use Initial U.S. Approval: 2025 | 20250630 |
| 07b0b671-db81-49f0-a402-0c0219db7fa2 | Andembry 200 MG per 1.2 ML Auto-Injector | SY | 5 | These highlights do not include all the information needed to use ANDEMBRY safely and effectively. See full prescribing information for ANDEMBRY. ANDEMBRY ® (garadacimab-gxii) injection, for subcutaneous use Initial U.S. Approval: 2025 | 20250630 |
| 07b0b671-db81-49f0-a402-0c0219db7fa2 | 1.2 ML garadacimab-gxii 167 MG/ML Auto-Injector [Andembry] | SBD | 5 | These highlights do not include all the information needed to use ANDEMBRY safely and effectively. See full prescribing information for ANDEMBRY. ANDEMBRY ® (garadacimab-gxii) injection, for subcutaneous use Initial U.S. Approval: 2025 | 20250630 |